Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 13:1513-1514, 2002
© 2002 European Society for Medical Oncology


News

RNA interference, a way ahead, not only to change the colour of flowers?

The first 150 words of the full text of this article appear below.

Post-transcriptional gene silencing (PTGS), which was initially considered a bizarre phenomenon limited to petunias and a few other plant species, is now one of the hottest topics in molecular biology. In the last few years, it has become clear that this phenomenon occurs in both plants and animals and has roles in viral defense and transposon silencing mechanisms. Perhaps most exciting, however, is the emerging use of PTGS and, in particular, RNA interference (RNAi)— PTGS initiated by the introduction of double-stranded RNA (dsRNA)—as a tool to knock out expression of specific genes in a variety of organisms. This mechanism has been the object of a series of remarkable review articles in Le Monde. Richard Jorgensen of the University of Arizona, Tucson, USA, was the first to observe the phenomenon, while studying the mechanism leading to the colour of petunias. Andrew Fire (Carnegie Institute, Washington), published 8 years later in . . . [Full Text of this Article]

Good news for South African AIDS patients

Swiss drug cost calculations

Will the league for protection of animals help humans who fight for a smoke-free environment?

Should men be encouraged to apply to medical school?

Drug companies accused of spending too little on research and development?

Dr Gro Harlem Brundtland, WHO Director-General, to quit in 2003

While AstraZeneca shares tumble 12% after the Iressa study data press release, OSI Pharmaceuticals and Genentech update on Tarceva


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?